ESPE Abstracts (2016) 86 RFC2.8

Final Heights and BMI in Patients Affected with Different Types of Pseudohypoparathyroidism

Patrick Hannaa, Giovanna Mantovanib, Virginie Grybekc, Harald Jüppnerd, Anne-Claire Brehine, Marie-Laure Kottlerg, Anya Rothenbuhlerh & Agnès Linglarti

aINSERM Bicêtre Paris Sud, Bicêtre Paris Sud, France; bMD, PhD, University of Milan, Milan, Italy; cPhD, INSERM Bicêtre Paris Sud, Bicêtre Paris Sud, France; dMassachusetts General Hospital and Harvard Medical School, Boston, USA; eMD, University Hospital and CMR Calcium-Phosphore, Normandy University, Caen, France; fMD, PhD, University Hospital and CMR Calcium-Phosphore, Normandy University, Caen, France; gMD, APHP, CMR Calcium-Phosphore, Bicêtre Paris Sud, France; hMD, PhD, OSI Araba University, Vitoria-Gasteiz, Spain; iMD, PhD, INSERM and APHP, CMR Calcium-Phosphore, Bicêtre Paris Sud, France

Background: Pseudohypoparathyroidism type 1A (PHP1A) and PseudoPHP are caused respectively by maternal and paternal mutations involving those GNAS exons that encode the alpha-subunit of the stimulatory G protein (Gsα). Common to different forms of PHP1B is a loss-of-methylation (LOM) at one or several maternal GNAS exons, which likely reduces Gsα expression in certain tissues. In most autosomal dominant PHP1B variants (AD-PHP1B), LOM is restricted to exon A/B and usually patients carry deletions affecting imprinting control elements; in contrast, sporadic PHP1B patients (sporPHP1B) display broad LOM at GNAS, yet lack deletions in the vicinity of this complex locus. PseudoPHP and, albeit to a less extent, PHP1A patients present with foetal and postnatal growth retardation, while PHP1B patients show with considerable overgrowth at birth.

Objective and methods: Compare the final heights (patients >18 years) and BMIs of 121 female (F) and 81 male (M) patients affected either by PHP1A (n=72), PseudoPHP (n=26), AD-PHP1B (n=33), or sporPHP1B (n=71).

Results: Median of final heights and BMIs of each cohort (Table 1). BMIs of females affected by PHP1B were higher than those of males. sporPHP1B patients (F: n=31; M: n=32): 1.2 vs 0.3, P=0.0001; AD-PHP1B patients (F: n=17; M: n=10): 1.8 vs 0.7, P=0.16. 52 and 16% of the female PHP1B patients are overweighed (z-BMI>1.0) or obese (z-BMI>2.0), respectively.

Table 1.
z-score (SD)
−2.8 (1.2)−2.9 (1.5)−0.3 (1.1)−0.3 (1.4)
z-score (SD)
1.3 (1.4)0.6 (1.7)0.7 (1.3)0.8 (1.9)

Conclusion: As previously described, patients with mutations in the coding sequence of GNAS have much reduced adult heights. Obesity was encountered only in PHP1A, not in PseudoPHP. Despite being born macrosomic, patients with LOM at the GNAS locus attained a normal final height and a normal BMI, suggesting a particular important role of GNAS in the regulation of foetal growth.

Article tools

My recent searches

No recent searches.